PolyMedix's Asset Sale

PolyMedix raised a round of funding on September 10, 2013. Investors include Cellceutix.

PolyMedix is a clinical stage biotechnology company developing small-molecule drugs designed to mimic the activity of host defense proteins (HDPs) for the treatment of infectious diseases and innate i…

Articles about PolyMedix's Asset Sale: